0001616308-24-000001.txt : 20240605 0001616308-24-000001.hdr.sgml : 20240605 20240604203503 ACCESSION NUMBER: 0001616308-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240604 EFFECTIVENESS DATE: 20240605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reiley Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001616308 ORGANIZATION NAME: IRS NUMBER: 471097516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515144 FILM NUMBER: 241020447 BUSINESS ADDRESS: STREET 1: 3749 BUCHANAN STREET STREET 2: SUITE 475745 CITY: SAN FRANCISCO STATE: CA ZIP: 94147 BUSINESS PHONE: 650 269-8044 MAIL ADDRESS: STREET 1: 3749 BUCHANAN STREET STREET 2: SUITE 475745 CITY: SAN FRANCISCO STATE: CA ZIP: 94147 D 1 primary_doc.xml X0708 D LIVE 0001616308 Reiley Pharmaceuticals, Inc. 3749 BUCHANAN STREET SUITE 475745 SAN FRANCISCO CA CALIFORNIA 94147 650 269-8044 DELAWARE None None Corporation true B. Michael Silber 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Keith Valentine 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Jeffrey Dunn 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Donald Kiepert 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2024-05-31 false true true false 2500 247132 97655 149477 false 6 0 0 0 false Reiley Pharmaceuticals, Inc. Donald Kiepert Donald Kiepert CEO 2024-06-04